Tempus Launches Psychiatric Real-World Data Collaboration
What You Should Know: – Tempus, an $8B precision medicine company, announced the launch of a new psychiatric real-world data program to leverage real-world data to inform […]
What You Should Know: – Tempus, an $8B precision medicine company, announced the launch of a new psychiatric real-world data program to leverage real-world data to inform […]
What You Should Know: – OncoHost, an AI-powered precision oncology platform, today announced a $35M Series C funding round led by ALIVE Israel HealthTech VC, […]
What You Should Know: – Today, Canopy announced it is launching out of stealth with $13 million in funding to work with leading oncology practices […]
CancerIQ Co-Founders Feyi Olopade Ayodele & Olufunmilayo (Funmi) Olopade, MD What You Should Know: – CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad […]
What You Should Know: – Jasper Health, an NYC-based cancer care coordination and experience platform raise $25M in Series A funding led by General Catalyst. – The round, […]
What You Should Know: – Syapse, a real-world evidence company that informs cancer care, announced that it will extend its collaboration with Pfizer to generate […]
What You Should Know: – Syapse, a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake […]
What You Should Know: – Syapse, a real-world evidence company that informs cancer care, announced a partnership with Bayhealth – central and southern Delaware’s largest […]
What You Should Know: – NeoGenomics, Inc., a provider of cancer-focused genetic testing services and global oncology contract research services announced it has reached an […]
What You Should Know: – Syapse raises 68M in equity investment led by Ally Bridge Group (ABG), with Northpond Ventures to expand delivery of real-world […]
What You Should Know: – COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care, has secured $34M in […]
What You Should Know: – RxVantage has acquired onPoint Oncology to provide cancer care teams with on-demand access to educational resources, reimbursement data, and analytics. – The acquisition of […]
What You Should Know: – CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment […]
Copyright © 2024 | WordPress Theme by MH Themes